Chlamydia is a major bacterial pathogen that infects humans, as well as a wide range of
animals, including marsupials, birds, cats, pigs, cattle, and sheep. Antibiotics are the only …

Attempts to produce a vaccine to protect against Chlamydia trachomatis-induced trachoma
were initiated more than 100 years ago and continued for several decades. Using whole …

Chlamydia trachomatis genital infection is a worldwide public health problem, and
considerable effort has been expended on developing an efficacious vaccine. The murine …

Introduction Chlamydia trachomatis is the most common sexually transmitted bacterial
pathogen in the world. Antibiotic treatment does not prevent against reinfection and a …

Despite effective antimicrobial chemotherapy, control of Chlamydia trachomatis urogenital
infection will likely require a vaccine. We have assessed the protective effect of an outer …

Citation Carey AJ, Beagley KW. Chlamydia trachomatis, a hidden epidemic: effects on the
female reproduction and options for treatment. Am J Reprod Immunol 2010 The number of …

MyD88, a key adaptor molecule required for many innate immunity receptor-activated
signaling pathways, was evaluated in a Chlamydia muridarum urogenital tract infection …

The failure of the inactivated Chlamydia-based vaccine trials in the 1960s has led
researchers studying Chlamydia to take cautious and rational approaches to develop safe …

Chlamydia trachomatis is the most common sexually transmitted bacterial infection
worldwide. The impact of this pathogen on human reproduction has intensified research …

We previously have shown the efficacy of recombinant (r) chlamydial protease-like activity
factor (CPAF) vaccination against hydrosalpinx development following primary genital …